The ruxolitinib compassionate use (CU) program offered ruxolitinib to patients ≥2 years of age with confirmed steroid-resistant acute or chronic graft-versus-host disease (aGvHD and cGvHD, ...
Low back pain (LBP) is a major health problem 1, considered the leading cause of years lived with disability 1 and of absenteeism. Although the impact on productivity varies in the literature 2, one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results